loadpatents
name:-0.0070309638977051
name:-0.0099630355834961
name:-0.00049591064453125
Klein; Barbara Kure Patent Filings

Klein; Barbara Kure

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klein; Barbara Kure.The latest application filed is for "interleukin-3 (il-3) multiple mutation polypeptides".

Company Profile
0.10.7
  • Klein; Barbara Kure - St. Louis MO
  • Klein, Barbara Kure - Town & Country MO
  • Klein, Barbara Kure - Town ?amp; Country MO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
IL-3 variant hematopoiesis fusion protein
Grant 7,091,319 - Bauer , et al. August 15, 2
2006-08-15
Interleukin-3 (IL-3) multiple mutation polypeptides
App 20050244372 - Bauer, S. Christopher ;   et al.
2005-11-03
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
App 20050059149 - Bauer, S. Christopher ;   et al.
2005-03-17
Interleukin-3 (IL-3) mutant polypeptides
App 20040018618 - Bauer, S. Christopher ;   et al.
2004-01-29
Interleukin-3 (IL-3) multiple mutation polypeptides
App 20030220472 - Bauer, S. Christopher ;   et al.
2003-11-27
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
App 20030185790 - Bauer, S. Christopher ;   et al.
2003-10-02
Methods of ex-vivo expansion of hematopoeitic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
App 20030165461 - Bauer, S. Christopher ;   et al.
2003-09-04
Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides
App 20030103936 - Bauer, S. Christopher ;   et al.
2003-06-05
Methods of using multivariant IL-3 hematopoiesis fusion protein
Grant 6,361,977 - Bauer , et al. March 26, 2
2002-03-26
Human interleukin-3 (IL-3) variant fusion proteins
Grant 6,132,991 - Bauer , et al. October 17, 2
2000-10-17
Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
Grant 6,093,395 - Bauer , et al. July 25, 2
2000-07-25
Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors
Grant 6,030,812 - Bauer , et al. February 29, 2
2000-02-29
Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors
Grant 6,022,535 - Bauer , et al. February 8, 2
2000-02-08
Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines
Grant 5,997,860 - Bauer , et al. December 7, 1
1999-12-07
Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
Grant 5,772,992 - Bauer , et al. June 30, 1
1998-06-30
Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
Grant 5,738,849 - Bauer , et al. * April 14, 1
1998-04-14
Interleukin-3 (IL-3) mutant polypeptides and their recombinant production
Grant 5,677,149 - Bauer , et al. October 14, 1
1997-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed